IMARA Inc.
MONOHYDRATE AND CRYSTALLINE FORMS OF 6-[(3S,4S)-4-METHYL-1-(PYRIMIDIN-2-YLMETHYL)PYRROLIDIN-3-YL]-3-TETRAHYDRO- PYRAN-4-YL-7H-IMIDAZO[1,5-A]PYRAZIN-8-ONE
Last updated:
Abstract:
The present disclosure relates to crystalline polymorph forms of 6-[(3S,4S)-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-3-tetrahydro- pyran-4-yl-7H-imidazol[1,5-a]pyrazin-8-one.
Status:
Application
Type:
Utility
Filling date:
2 Dec 2020
Issue date:
15 Apr 2021